Mednax Inc (MD) - Total Liabilities
Based on the latest financial reports, Mednax Inc (MD) has total liabilities worth $1.31 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Mednax Inc to assess how effectively this company generates cash.
Mednax Inc - Total Liabilities Trend (1994–2024)
This chart illustrates how Mednax Inc's total liabilities have evolved over time, based on quarterly financial data. Check Mednax Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Mednax Inc Competitors by Total Liabilities
The table below lists competitors of Mednax Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Stoke Therapeutics Inc
NASDAQ:STOK
|
USA | $52.16 Million |
|
Mesoblast Ltd
NASDAQ:MESO
|
USA | $207.62 Million |
|
Sirius Real Estate Ltd
JSE:SRE
|
South Africa | ZAC1.66 Billion |
|
Nantong Jiangshan Agrochemical & Chemicals Co Ltd
SHG:600389
|
China | CN¥5.07 Billion |
|
Pharvaris BV
NASDAQ:PHVS
|
USA | $26.66 Million |
|
TianJin 712 Communication & Broadcasting Co Ltd
SHG:603712
|
China | CN¥4.67 Billion |
|
John Wiley & Sons
NYSE:WLY
|
USA | $1.79 Billion |
|
DANAOS CORP. DL -01
F:DVW1
|
Germany | €1.32 Billion |
Liability Composition Analysis (1994–2024)
This chart breaks down Mednax Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Mednax Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.87 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mednax Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mednax Inc (1994–2024)
The table below shows the annual total liabilities of Mednax Inc from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.39 Billion | +1.24% |
| 2023-12-31 | $1.37 Billion | -5.87% |
| 2022-12-31 | $1.46 Billion | -20.24% |
| 2021-12-31 | $1.83 Billion | -29.78% |
| 2020-12-31 | $2.60 Billion | -1.76% |
| 2019-12-31 | $2.65 Billion | -7.03% |
| 2018-12-31 | $2.85 Billion | +1.65% |
| 2017-12-31 | $2.80 Billion | +8.62% |
| 2016-12-31 | $2.58 Billion | +22.25% |
| 2015-12-31 | $2.11 Billion | +57.04% |
| 2014-12-31 | $1.34 Billion | +90.14% |
| 2013-12-31 | $706.44 Million | -1.19% |
| 2012-12-31 | $714.97 Million | +32.00% |
| 2011-12-31 | $541.63 Million | -8.23% |
| 2010-12-31 | $590.19 Million | +18.22% |
| 2009-12-31 | $499.25 Million | -6.11% |
| 2008-12-31 | $531.74 Million | +54.69% |
| 2007-12-31 | $343.75 Million | +27.61% |
| 2006-12-31 | $269.37 Million | +29.12% |
| 2005-12-31 | $208.61 Million | -4.24% |
| 2004-12-31 | $217.86 Million | +50.02% |
| 2003-12-31 | $145.22 Million | +44.23% |
| 2002-12-31 | $100.68 Million | +6.83% |
| 2001-12-31 | $94.25 Million | +13.78% |
| 2000-12-31 | $82.83 Million | -21.78% |
| 1999-12-31 | $105.90 Million | +67.30% |
| 1998-12-31 | $63.30 Million | +91.24% |
| 1997-12-31 | $33.10 Million | +45.81% |
| 1996-12-31 | $22.70 Million | +219.72% |
| 1995-12-31 | $7.10 Million | +69.05% |
| 1994-12-31 | $4.20 Million | -- |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric … Read more